Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remedios Otero

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Thrombosis Research|June 2, 2020
Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)Javier de Miguel-Diez, Isabel Blasco-Esquivias, Consolacion Rodriguez-Matute, et al.
JAMA|October 5, 2021
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical TrialDavid Jiménez, Alvar Agustí, Eva Tabernero, et al.
Thrombosis Research|June 1, 2023
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS studyRemedios Otero, José Luis Lobo, Raquel López, et al.
Eclinicalmedicine|September 21, 2023
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysisMarte A M van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, et al.
Cancers|January 1, 2020
A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) StudyLucia Marin-Barrera, Andres J Muñoz-Martin, Eduardo Rios-Herranz, et al.
British Journal of Cancer|October 16, 2018
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosisLuis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, et al.
European Heart Journal|July 12, 2024
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysisDieuwke Luijten, Delphine Douillet, Kim Luijken, et al.
Thorax|December 5, 2023
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE studySamira Marin-Romero, Aitor Ballaz-Quincoces, Covadonga Gómez-Cuervo, et al.
Thrombosis Research|June 27, 2025
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohortsElva Mendoza-Zambrano, Aitor Ballaz-Quincoces, Jose Luis Lobo, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Thrombosis Research|June 2, 2020
Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)Javier de Miguel-Diez, Isabel Blasco-Esquivias, Consolacion Rodriguez-Matute, et al.
JAMA|October 5, 2021
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical TrialDavid Jiménez, Alvar Agustí, Eva Tabernero, et al.
Thrombosis Research|June 1, 2023
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS studyRemedios Otero, José Luis Lobo, Raquel López, et al.
Eclinicalmedicine|September 21, 2023
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysisMarte A M van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, et al.
Cancers|January 1, 2020
A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) StudyLucia Marin-Barrera, Andres J Muñoz-Martin, Eduardo Rios-Herranz, et al.
British Journal of Cancer|October 16, 2018
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosisLuis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, et al.
European Heart Journal|July 12, 2024
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysisDieuwke Luijten, Delphine Douillet, Kim Luijken, et al.
Thorax|December 5, 2023
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE studySamira Marin-Romero, Aitor Ballaz-Quincoces, Covadonga Gómez-Cuervo, et al.
Thrombosis Research|June 27, 2025
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohortsElva Mendoza-Zambrano, Aitor Ballaz-Quincoces, Jose Luis Lobo, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Pageof 12